Literature DB >> 1931604

Glutathione restores normal cell activation and cell cycle progression in cis-platinum treated human lymphocytes.

M Kubbies1, B Goller, B Schetters, I Bartosek, W Albert.   

Abstract

Cis-platinum (CDDP) induces severe inhibition of cell activation and cell cycle progression in PHA-stimulated human PBL's. Applying the novel BrdU/Hoechst flow cytometric technique for high resolution cell cycle analysis we show that CDDP induced multiple cell kinetic disturbances occur simultaneously comprising G0/G1-arrest, and slow down and arrest of cells in S and G2/M-phase. We investigated whether the administration of reduced glutathione (GSH) might rescue cells from proliferative disturbances induced by CDDP. GSH at 0.15 mg ml-1 only partially restored normal cell activation and cell cycle progression. However, at 1.5 mg ml-1 a complete normal proliferation pattern was obtained. At the highest GSH dose rescue from inhibition of cell activation (G0/G1-phase arrest) as well as of cell cycle progression (S- and G2/M-phase arrest) was also present after delayed addition of GSH (1, 4 and 20 h) to CDDP treated PBL's. In addition cell viability of CDDP exposed PBL's is restored after GSH treatment. Our in vitro experiments give evidence that an increase of WBC found in CDDP/GSH treated patients has a real underlying cellular physiological mechanism protecting human peripheral lymphocytes from CDDP toxicity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1931604      PMCID: PMC1977464          DOI: 10.1038/bjc.1991.411

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  34 in total

Review 1.  Historical aspects of glutathione and cancer chemotherapy.

Authors:  P Mistry; K R Harrap
Journal:  Pharmacol Ther       Date:  1991       Impact factor: 12.310

Review 2.  Glutathione.

Authors:  A Meister; M E Anderson
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

3.  Regulation of human fibroblast growth rate by both noncycling cell fraction transition probability is shown by growth in 5-bromodeoxyuridine followed by Hoechst 33258 flow cytometry.

Authors:  P S Rabinovitch
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

Review 4.  The glutathione status of cells.

Authors:  N S Kosower; E M Kosower
Journal:  Int Rev Cytol       Date:  1978

5.  Thiourea reverses cross-links and restores biological activity in DNA treated with dichlorodiaminoplatinum (II).

Authors:  J Filipski; K W Kohn; R Prather; W M Bonner
Journal:  Science       Date:  1979-04-13       Impact factor: 47.728

6.  Effect of diethyldithiocarbamate rescue on tumor response to cis-platinum in a rat model.

Authors:  R F Borch; J C Katz; P H Lieder; M E Pleasants
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

7.  cis-Pt(NH3)2Cl2 and trans-Pt(NH3)2Cl2 inhibit DNA synthesis in cultured L1210 leukemia cells.

Authors:  B Salles; J L Butour; C Lesca; J P Macquet
Journal:  Biochem Biophys Res Commun       Date:  1983-04-29       Impact factor: 3.575

8.  Protection against cis-dichlorodiammine Pt (II) cytotoxicity in vitro by cysteamine.

Authors:  D C Shrieve; J W Harris
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982 Mar-Apr       Impact factor: 7.038

9.  New chemistry of an old molecule: cis-[Pt(NH3)2Cl2].

Authors:  S J Lippard
Journal:  Science       Date:  1982-12-10       Impact factor: 47.728

10.  Protective effect of reduced glutathione against cis-dichlorodiammine platinum (II)-induced nephrotoxicity and lethal toxicity.

Authors:  F Zunino; O Tofanetti; A Besati; E Cavalletti; G Savi
Journal:  Tumori       Date:  1983-04-30
View more
  1 in total

Review 1.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.